221 related articles for article (PubMed ID: 7672999)
1. [Immunoglobulin for prevention of radiogenic mucositis].
Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
[TBL] [Abstract][Full Text] [Related]
2. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
Dietz A; Nollert J; Maier H; Rudat V; Flentje M
HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
[TBL] [Abstract][Full Text] [Related]
3. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
5. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Altmann S; Hoffmanns H
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
[TBL] [Abstract][Full Text] [Related]
6. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
7. [Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?].
Gava A; Ferrarese F; Tonetto V; Coghetto F; Marazzato G; Zorat PL
Radiol Med; 1996 Apr; 91(4):452-5. PubMed ID: 8643858
[TBL] [Abstract][Full Text] [Related]
8. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
[TBL] [Abstract][Full Text] [Related]
9. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
10. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
[TBL] [Abstract][Full Text] [Related]
13. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].
Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF
Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
15. [Z-100 as radiation mucositis protector in head and neck tumor management].
Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707
[TBL] [Abstract][Full Text] [Related]
16. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
[TBL] [Abstract][Full Text] [Related]
18. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
[TBL] [Abstract][Full Text] [Related]
19. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
20. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
Russo G; Haddad R; Posner M; Machtay M
Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
